The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer

Current Opinion in Immunology

Volumn 20, Issue 3, 2008, Pages 295-301

  Spolski, Rosanne ^a   Leonard, Warren J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; INTERLEUKIN 13; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGIC RHINITIS; ALLERGY; ANTINEOPLASTIC ACTIVITY; ASTHMA; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; GENE CONTROL; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOGLOBULIN PRODUCTION; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; NEOPLASMS; RECEPTORS, INTERLEUKIN-21;

EID: 45449104408     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.02.004     Document Type: Review

References (50)

1. Spolski R., and Leonard W.J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol (2007). This review offers the most comprehensive review of the regulation, signaling, and biology of IL-21, including actions within both lymphoid and myeloid cell lineages.
2. Noguchi M., Yi H., Rosenblatt H.M., Filipovich A.H., Adelstein S., Modi W.S., McBride O.W., and Leonard W.J. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73 (1993) 147-157
3. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher A., Morse III H.C., Liu C., Schwartzberg P.L., and Leonard W.J. A critical role for IL-21 in regulating immunoglobulin production. Science 298 (2002) 1630-1634
4. Kim H.P., Korn L.L., Gamero A.M., and Leonard W.J. Calcium-dependent activation of interleukin-21 gene expression in T cells. J Biol Chem 280 (2005) 25291-25297
5. Wu Z., Kim H.P., Xue H.H., Liu H., Zhao K., and Leonard W.J. Interleukin-21 receptor gene induction in human T cells is mediated by T-cell receptor-induced Sp1 activity. Mol Cell Biol 25 (2005) 9741-9752
6. Zeng R., Spolski R., Casas E., Zhu W., Levy D.E., and Leonard W.J. The molecular basis of IL-21-mediated proliferation. Blood 109 (2007) 4135-4142. This article provides the most detailed analysis of signaling via IL-21.
7. Ozaki K., Spolski R., Ettinger R., Kim H.P., Wang G., Qi C.F., Hwu P., Shaffer D.J., Akilesh S., Roopenian D.C., et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 173 (2004) 5361-5371
8. Jin H., Carrio R., Yu A., and Malek T.R. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol 173 (2004) 657-665
9. Mehta D.S., Wurster A.L., Whitters M.J., Young D.A., Collins M., and Grusby M.J. IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol 170 (2003) 4111-4118
10. Ettinger R., Sims G.P., Fairhurst A.M., Robbins R., da Silva Y.S., Spolski R., Leonard W.J., and Lipsky P.E. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 175 (2005) 7867-7879
11. Suto A., Nakajima H., Hirose K., Suzuki K., Kagami S., Seto Y., Hoshimoto A., Saito Y., Foster D.C., and Iwamoto I. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C (epsilon) transcription of IL-4-stimulated B cells. Blood 100 (2002) 4565-4573
12. Harada M., Magara-Koyanagi K., Watarai H., Nagata Y., Ishii Y., Kojo S., Horiguchi S., Okamoto Y., Nakayama T., Suzuki N., et al. IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses. J Exp Med 203 (2006) 2929-2937
13. Kishida T., Hiromura Y., Shin-Ya M., Asada H., Kuriyama H., Sugai M., Shimizu A., Yokota Y., Hama T., Imanishi J., et al. IL-21 induces inhibitor of differentiation 2 and leads to complete abrogation of anaphylaxis in mice. J Immunol 179 (2007) 8554-8561. This article illustrates the strong therapeutic potential of IL-21 as a cytokine that can suppress IgE-mediated anaphylaxis and describes this effect as being mediated by the IL-21 induction of Id2, a repressor of IgE class switch recombination.
14. Bryant V.L., Ma C.S., Avery D.T., Li Y., Good K.L., Corcoran L.M., de Waal Malefyt R., and Tangye S.G. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol 179 (2007) 8180-8190
15. Kuchen S., Robbins R., Sims G.P., Sheng C., Phillips T.M., Lipsky P.E., and Ettinger R. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol 179 (2007) 5886-5896
16. Hiromura Y., Kishida T., Nakano H., Hama T., Imanishi J., Hisa Y., and Mazda O. IL-21 administration into the nostril alleviates murine allergic rhinitis. J Immunol 179 (2007) 7157-7165
17. Frohlich A., Marsland B.J., Sonderegger I., Kurrer M., Hodge M.R., Harris N.L., and Kopf M. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109 (2007) 2023-2031
18. Chtanova T., Tangye S.G., Newton R., Frank N., Hodge M.R., Rolph M.S., and Mackay C.R. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 173 (2004) 68-78
19. Wurster A.L., Rodgers V.L., Satoskar A.R., Whitters M.J., Young D.A., Collins M., and Grusby M.J. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med 196 (2002) 969-977
20. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., and Littman D.R. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8 (2007) 967-974. Articles 20-22 presented the first evidence for the essential role played by IL-21 in the development and function of the recently described Th17 lineage, including its role in the development of autoimmune pathology in experimental allergic encephalitis.
21. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., Oukka M., and Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 (2007) 484-487
22. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (2007) 480-483
23. Coquet J.M., Kyparissoudis K., Pellicci D.G., Besra G., Berzins S.P., Smyth M.J., and Godfrey D.I. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol 178 (2007) 2827-2834
24. Pesce J., Kaviratne M., Ramalingam T.R., Thompson R.W., Urban Jr. J.F., Cheever A.W., Young D.A., Collins M., Grusby M.J., and Wynn T.A. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 116 (2006) 2044-2055
25. Suto A., Wurster A.L., Reiner S.L., and Grusby M.J. IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of eomesodermin expression. J Immunol 177 (2006) 3721-3727
26. Bettelli E., Oukka M., and Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8 (2007) 345-350
27. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
28. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., and Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006) 1121-1133
29. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240
30. Peluso I., Fantini M.C., Fina D., Caruso R., Boirivant M., MacDonald T.T., Pallone F., and Monteleone G. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 178 (2007) 732-739
31. Li Y., and Yee C. IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes. Blood 111 (2008) 229-235
32. Zeng R., Spolski R., Finkelstein S.E., Oh S., Kovanen P.E., Hinrichs C.S., Pise-Masison C.A., Radonovich M.F., Brady J.N., Restifo N.P., et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med 201 (2005) 139-148
33. Li Y., Bleakley M., and Yee C. IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. J Immunol 175 (2005) 2261-2269
34. White L., Krishnan S., Strbo N., Liu H., Kolber M.A., Lichtenheld M.G., Pahwa R.N., and Pahwa S. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood 109 (2007) 3873-3880
35. Moroz A., Eppolito C., Li Q., Tao J., Clegg C.H., and Shrikant P.A. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J Immunol 173 (2004) 900-909
36. Sondergaard H., Frederiksen K.S., Thygesen P., Galsgaard E.D., Skak K., Kristjansen P.E., Odum N., and Kragh M. Interleukin 21 therapy increases the density of tumor infiltrating CD8(+)T cells and inhibits the growth of syngeneic tumors. Cancer Immunol Immunother (2007)
37. He H., Wisner P., Yang G., Hu H.M., Haley D., Miller W., O'Hara A., Alvord W.G., Clegg C.H., Fox B.A., et al. Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model. J Transl Med 4 (2006) 24
38. + T cells by IL-21 during in vitro priming, which leads to enhanced anti-tumor activity upon secondary encounter with tumor cells in vivo. This IL-21 programming was found to be opposed by the presence of IL-2 during the priming event.
39. Smyth M.J., Hayakawa Y., Cretney E., Zerafa N., Sivakumar P., Yagita H., and Takeda K. IL-21 enhances tumor-specific CTL induction by anti-DR5 antibody therapy. J Immunol 176 (2006) 6347-6355
40. Davis I.D., Skrumsager B.K., Cebon J., Nicholaou T., Barlow J.W., Moller N.P., Skak K., Lundsgaard D., Frederiksen K.S., Thygesen P., et al. An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma. Clin Cancer Res 13 (2007) 3630-3636
41. Vinuesa C.G., Cook M.C., Angelucci C., Athanasopoulos V., Rui L., Hill K.M., Yu D., Domaschenz H., Whittle B., Lambe T., et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435 (2005) 452-458
42. King C., Ilic A., Koelsch K., and Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117 (2004) 265-277
43. Yamanouchi J., Rainbow D., Serra P., Howlett S., Hunter K., Garner V.E., Gonzalez-Munoz A., Clark J., Veijola R., Cubbon R., et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 39 (2007) 329-337
44. Herber D., Brown T.P., Liang S., Young D.A., Collins M., and Dunussi-Joannopoulos K. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol 178 (2007) 3822-3830
45. Li J., Shen W., Kong K., and Liu Z. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand J Immunol 64 (2006) 515-522
46. Young D.A., Hegen M., Ma H.L., Whitters M.J., Albert L.M., Lowe L., Senices M., Wu P.W., Sibley B., Leathurby Y., et al. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 56 (2007) 1152-1163
47. Vollmer T.L., Liu R., Price M., Rhodes S., La Cava A., and Shi F.D. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 174 (2005) 2696-2701
48. Piao W.H., Jee Y.H., Liu R.L., Coons S.W., Kala M., Collins M., Young D.A., Campagnolo D.I., Vollmer T.L., Bai X.F., et al. IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scand J Immunol 67 (2008) 37-46
49. Ozaki K., Kikly K., Michalovich D., Young P.R., and Leonard W.J. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A 97 (2000) 11439-11444
50. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., Johnston J., Madden K., Xu W., West J., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408 (2000) 57-63